Visiongain Report Offers Transformative Insights on the $2.9bn Vaccine Contract Manufacturing Market

Global Vaccine Contract Manufacturing Market Report 2019-2029

News provided by

20 May, 2019, 09:00 GMT

LONDON, May 20, 2019 /PRNewswire/ -- Paediatric Vaccines, Adult Vaccines, Influenza Vaccines, Therapeutic Vaccines, Downstream Processing, Fill & Finish Operations, Analytical & QC Studies, Packaging, Upstream Processing, Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

The global vaccine contract manufacturing market was worth $1.9bn in 2018 and is expected to grow at a CAGR of 9.3% from 2019-2023. In 2018, the paediatric vaccines segment held 48% of the global vaccine contract manufacturing market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 217-page report you will receive 80 tables and 57 figures– all unavailable elsewhere.

Visiongain report provides clear detailed insight into the global vaccine contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-vaccine-contract-manufacturing-market-report-2019-2029/#download_sampe_div

Report Scope

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine market

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by type:
• Paediatric Vaccines
• Adult Vaccines
• Influenza Vaccines
• Therapeutic Vaccines

• Revenue and growth forecasts from 2019 to 2029 for the global vaccine contract manufacturing market by workflow:
• Downstream Processing: the revenues are further broken down into Fill & Finish Operations, Analytical & QC Studies, Packaging
• Upstream Processing: the revenues are further broken down into Mammalian Expression Systems, Bacterial Expression Systems, Yeast Expression Systems, Baculovirus/Insect Expression Systems, Other Upstream Processing

• Revenue and growth forecasts from 2019 to 2029 for the leading regional and national markets:
• North America: the revenues are further broken down into the US and Canada
• Europe: the revenues are further broken down into the UK, Germany, France, Italy and Spain
• Asia-Pacific: the revenues are further broken down into China, Japan and India
• Rest of the World: the revenues are further broken down into Brazil, Mexico, Russia and South Africa

The regional markets are further broken down by type and workflow.

• Discussion and profiles of the leading players in the vaccine contract manufacturing market:
• AbbVie
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• Evonik Degusa
• IDT Biologika
• Lonza
• Meridian Life Science
• Nipro Corporation
• Pfizer CentreOne
• Sigma Aldrich Fine Chemicals
• SynCo Bio Partners
• Vetter Pharmaceutical

• A SWOT analysis discussing the industry trends, strengths, weaknesses, opportunities and threats.

• Discussion on vaccine manufacturing technologies covering new substrates for vaccine production, next-generation expression systems and vectors, equipment trends, pre-filled syringes and vaccines, lyophilization and vaccine manufacturing, cell-based techniques.

• Key Questions Answered by this Report:
• How is the vaccine contract manufacturing market evolving?
• What is driving and restraining the vaccine contract manufacturing market?
• What are the market shares of the leading segments of the vaccine contract manufacturing market in 2018?
• What is the value of the leading sectors in important regions of the world?
• What will be the main driver of the overall market from 2019 to 2029?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the leading national markets change by 2029 and which country will lead the market in 2029?
• How will the industry evolve during the period between 2019 and 2029?

To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/global-vaccine-contract-manufacturing-market-report-2019-2029/

Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.

Companies covered in the report include:

AbbVie
Accugenix
AfriVax
Alkion Biopharma SAS
AmProtein
Antigenics, Inc.
Arabio
Argenta
Artelis
Astrazeneca
ATM Life Sciences
ATMI
Bacteriological Institute of the Anhaltian Administrative Areas
Batavia Bioservices
Baxter BioPharma
Berna Biotech
Bharat Biotech International Limited
Binnopharm
BioFocus
Biovest
Boehringer Ingelheim
Bristol-Myers Squibb Company
Cadila Pharmaceuticals
Calico
Catalent
Cellexus Limited
Charles River Laboratories
Chemisch-Pharmazeutisches Laboratorium Ravensburg
Colorcon
Crucell
CSL Biotherapies
Daiichi Sankyo Co. Ltd.
Elanco
Eli Lilly
Evonik Degussa
FiberCell
Gallant Custom Laboratories
GE Healthcare
GE Wave Biotech
GlaxoSmithKline Biologics
GSAL
GlaxoSmithKline (GSK)
Hikma
Hyclone
IDT Biologika GmbH
Intercell Corporation
Invitrogen
Irvine Scientific
Janssen Biotech, Inc. (Janssen)
Klocke Group
Kuhner
LG Life Sciences
Lonza
Medicago
Meissner Filtration
Merck & Company
Merck Millipore
Meridian Bioscience
Meridian Life Science
MGC Pharma Co.
Millipore
Mitsubishi Tanabe Pharma
MorphoSys
Mosquirix
MP Biomedicals
Mylan
Neurocrine Biosciences
Nipro Corporation
Novartis
Novartis Vaccines and Diagnostics
Novavax
Organon Teknika Corporation
Pall Life Sciences
PATH
Patheon
Pfizer
Pharmaceutical Base Development Co., Ltd.
Pharmacyclics LLC
Philip Morris International
Pierre-Guerin Biolafitte
Protein Sciences Corporation
Refine Technology
Samsung Bioepis
Sanofi
Sanofi Pasteur
Sartorius Stedim Biotech
Scripps Research
Shanghai Zhangjiang Biotech
ShangPharma Corporation
Sigma Aldrich
Sigma-Aldrich Fine Chemicals
SynCo Bio Partners
SynCo Bio Partners (SynCo)
Thermo Fisher
Vetter Pharmaceutical
Vivalis
Voyager Therapeutics, Inc.
Wave Biotech (GE Healthcare Life Sciences)
Wynca
Xcellerex (GE Healthcare Life Sciences)
ZellWerk
Zhejiang Jiang Yuan Tang Biotechnology Corporation

List of Organizations Mentioned in the Report
Centers for Disease Control and Prevention (CDC)
Defense Advanced Research Projects Agency (DARPA)
European Medicine Agency (EMA)
Food and Drug Administration (FDA)
Institute Pasteur in Paris
Japanese Ministry of Health, Labour and Welfare (MHLW)
National Institute of Allergy and Infectious Diseases (NIAID)